Metropolitan Bank vs Meridian
MCB and MRBK side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MCB and MRBK compare
Metropolitan Bank is the larger company, worth 6.0 times as much as Meridian ($1.2B against $199M).
On earnings, Metropolitan Bank is cheaper: it trades at 9.8× trailing earnings, against 9.9× for Meridian.
Meridian grew revenue faster over the last twelve months (13.4% versus −18.5% for Metropolitan Bank).
Metropolitan Bank keeps more of each dollar of sales as profit, with a net margin of 1041% compared with 289% at Meridian.
Both pay dividends: Metropolitan Bank yields 0.83% and Meridian 3.4%.
Metropolitan Bank scores higher on the StockData Score (16 against 12 for Meridian), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MCB | MRBK |
|---|---|---|
| Size and price | ||
| Market cap | $1.2B | $199M |
| Share price | $96.51 | $16.71 |
| Change, 1 year | 41.5% | 13.6% |
| Change, 5 years | −2.9% | −9.2% |
| Beta (5Y) | 0.98 | 0.71 |
| Employees | 326 | 327 |
| StockData Score | ||
| Total score | 16 (better) | 12 |
| Valuation score | 4 (better) | 3 |
| Growth score | 1 | 2 (better) |
| Performance score | 5 (better) | 2 |
| Health score | 4 (better) | 3 |
| Dividend score | 2 | 2 |
| Valuation | ||
| P/E | 9.8× (better) | 9.9× |
| P/S | 111× | 28.5× (better) |
| P/B | 1.2× | 1.0× (better) |
| P/FCF | – | 28.2× |
| PEG | 1.27 (better) | 5.41 |
| FCF yield | – | 3.6% |
| Fair value | $101.86 | $18.59 |
| Margin of safety | 5.3% | 10.1% (better) |
| Growth | ||
| Revenue growth (TTM) | −18.5% | 13.4% (better) |
| Revenue growth, 5Y average | −4.2% (better) | −45.9% |
| Net income growth (TTM) | 75.9% (better) | −0.22% |
| EPS growth (TTM) | 70.3% (better) | −4.5% |
| EPS growth, 5Y average | 7.3% (better) | −2.4% |
| Profitability | ||
| Net margin | 1041% (better) | 289% |
| FCF margin | – | 101% |
| Return on equity | 13.1% (better) | 10.3% |
| Financial health | ||
| Debt / equity | – | 0.57 |
| Altman Z-score | 0.16 (better) | 0.13 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.83% | 3.4% (better) |
| Payout ratio | 10.1% | 31.8% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | – | 32.0% |
| Buyback yield | 3.3% | – |
| Shareholder yield | 4.2% (better) | 3.4% |
| Ownership | ||
| Held by institutions | 90.9% | 65.0% |
| Held by insiders | 10.0% | 11.0% |
| Insider net buying, 12 months | −$4.4M | $53.8K (better) |
| Short interest, % of float | 5.8% | 2.0% |
Go deeper
- MCB stock overview
- MCB income statement
- MCB valuation and score
- MRBK stock overview
- MRBK income statement
- MRBK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.